| |
UBRELVY™ is a prescription medicine used for the
acute treatment of migraine attacks with or without aura in
adults. UBRELVY is not used to prevent migraine headaches.
|
|
| |
INTRODUCING UBRELVY
While over-the-counter Excedrin® Migraine is
temporarily unavailable, talk to your healthcare provider to see if prescription UBRELVY is right for you. It's a new medicine that treats migraine pain and symptoms. UBRELVY has a safety profile that allows you to take it whenever, wherever you need it.
YOU MAY PAY AS LITTLE
AS $1 PER PILL*
See if you’re eligible for exclusive savings and learn more about UBRELVY now!
*Terms and Conditions apply. This offer is valid only for commercially insured patients. Offer not valid for patients enrolled in Medicare, Medicaid, or other federal or state healthcare programs. Please review full Program Terms, Conditions, and Eligibility Criteria.
DISCOVER UBRELVY
Two clinical studies evaluated the following outcomes at 2 hours after taking 1 dose
of UBRELVY:
|
|
| |
The majority of patients achieved pain relief
(reduction in pain) and 1 in 5 experienced
total pain freedom. Many also reported
absence of their most bothersome symptom.
|
|
| |
Important Safety Information
Who should not take UBRELVY™(ubrogepant)?
Do not take UBRELVY if you are taking medicines
known as strong CYP3A4 inhibitors, such as
ketoconazole, clarithromycin, itraconazole.
What should I tell my healthcare provider before
taking UBRELVY?
Tell your healthcare provider about all your medical
conditions, including if you:
- Have liver problems
- Have kidney problems
- Are pregnant or plan to become pregnant
- Are breastfeeding or plan to breastfeed
Tell your healthcare provider about all the
medicines you take, including prescription and
over-the-counter medicines, vitamins, and herbal supplements. Your healthcare provider can tell you
if it is safe to take UBRELVY with other medicines.
What are the most common side effects
of UBRELVY?
The most common side effects are nausea (4%) and sleepiness (3%). These are not all of the possible side effects of UBRELVY.
What is UBRELVY™ (ubrogepant)?
UBRELVY is a prescription medicine used for the
acute treatment of migraine attacks with or without
aura in adults. UBRELVY is not used to prevent
migraine headaches.
Please see full Patient Information.
|
|
| |
We respect your privacy. See our Privacy Policy
and California Privacy Policy statements.
Allergan USA, Inc.
5 Giralda Farms
Madison, NJ 07940
Allergan® and its design are trademarks of Allergan, Inc.
UBRELVY™ and its design are trademarks of Allergan Pharmaceuticals International Limited. All trademarks are the property of their respective owners.
© 2020 Allergan. All rights reserved.
UBR133165-V1 03/20
|
|
| |
Please add %%SENDER%% to your e-mail address to ensure our e-mails reach your inbox.
This e-mail was sent from
Migraine.com, a property of Health Union, LLC, 1 International Plaza, Suite 550 Philadelphia, PA 19113. We are sending this e-mail to you on behalf of our sponsor; your e-mail address has not been shared with the sponsor. To unsubscribe, click here.
©2010-20 Health
Union. All rights reserved. This information is not designed to replace a physician's
independent judgment about the appropriateness or risks of a procedure for a given patient. Always consult your doctor about your medical conditions.
Migraine.com does not provide medical advice, diagnosis or treatment. Use of the site is conditional upon your acceptance of our terms of use.
|
|
|
|
UBRELVY™ is a prescription medicine used for the acute treatment of migraine attacks with or without aura in adults.
UBRELVY is not used to prevent migraine headaches.
|
|
INTRODUCING UBRELVY
While over-the-counter Excedrin® Migraine is temporarily unavailable, talk to your healthcare provider to see if prescription UBRELVY is right for you. It's a new medicine that treats migraine pain and symptoms. UBRELVY has a safety profile that allows you to take it whenever, wherever you need it.
YOU MAY PAY AS LITTLE AS $1 PER PILL*
See if you’re eligible for exclusive savings and learn more about UBRELVY now!
*Terms and Conditions apply. This offer is valid only for commercially insured patients. Offer not valid for patients enrolled in Medicare, Medicaid, or other federal or state healthcare programs. Please review full Program Terms, Conditions, and Eligibility Criteria.
DISCOVER UBRELVY
Two clinical studies evaluated the following outcomes at 2 hours after taking 1 dose
of UBRELVY:
|
|
The majority of patients achieved pain relief (reduction in pain) and 1 in 5 experienced total pain freedom. Many also reported absence of their most bothersome symptom.
|
|
Important Safety Information
Who should not take UBRELVY™(ubrogepant)?
Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, itraconazole.
What should I tell my healthcare provider before taking UBRELVY?
Tell your healthcare provider about all your medical conditions, including if you:
- Have liver problems
- Have kidney problems
- Are pregnant or plan to become pregnant
- Are breastfeeding or plan to breastfeed
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Your healthcare provider can tell you if it is safe to take UBRELVY with other medicines.
What are the most common side effects of UBRELVY?
The most common side effects are nausea (4%) and sleepiness (3%). These are not all of the possible side effects of UBRELVY.
What is UBRELVY™ (ubrogepant)?
UBRELVY is a prescription medicine used for the acute treatment of migraine attacks with or without aura in adults. UBRELVY is not used to prevent migraine headaches.
Please see full Patient Information.
|
|
|
|
Allergan USA, Inc.
5 Giralda Farms
Madison, NJ 07940
Allergan® and its design are trademarks of Allergan, Inc.
UBRELVY™ and its design are trademarks of Allergan Pharmaceuticals International Limited.
All trademarks are the property of their respective owners.
© 2020 Allergan. All rights reserved.
UBR133165-V1 03/20
|
|
Please add %%SENDER%% to your e-mail address to ensure our e-mails reach your inbox.
This e-mail was sent from
Migraine.com, a property of Health Union, LLC, 1 International Plaza, Suite 550 Philadelphia, PA 19113. We are sending this e-mail to you on behalf of our sponsor; your e-mail address has not been shared with the sponsor. To unsubscribe, click here.
©2010-20 Health
Union. All rights reserved. This information is not designed to replace a physician's
independent judgment about the appropriateness or risks of a procedure for a given patient. Always consult your doctor about your medical conditions.
Migraine.com does not provide medical advice, diagnosis or treatment. Use of the site is conditional upon your acceptance of our terms of use.
|
|
|
